Company profile: Genewiz
1.1 - Company Overview
Company description
- Provider of global genomics services, including DNA sequencing, gene synthesis, molecular biology, next-generation sequencing, bioinformatics, and GLP regulatory services. Offerings include GLP-compliant SNP/mutation analysis, plasmid prep, biofluid processing, nucleic acid extraction, integration site analysis for cell and gene therapy, and AAV services.
Products and services
- Integration Site Analysis for Cell and Gene Therapy: Delivers pre-optimized, clinical-trial-ready protocols to analyze integration sites during clinical trials, ensuring data confidence for cell and gene therapy applications
- Adeno-Associated VIRUS (AAV) Services: Supplies in vivo-focused AAV services, including AAV-ITR sequencing, plasmid synthesis, packaging, and preparation to support gene therapy research
- GLP-Compliant Plasmid Prep Services: Offers GLP-compliant plasmid DNA preparation services meeting FDA and EPA GLP standards for pre-clinical development in regulated studies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genewiz
Arbor Biotechnologies
HQ: United States
Website
- Description: Provider of next-generation gene editing therapeutics and tools to create targeted genetic medicines for liver and CNS diseases, supported by an AI/ML-powered discovery engine for high-throughput screening. Develops lipid nanoparticle-delivered liver therapies, AAV-delivered CNS therapies, and partners on ex vivo cell-based therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arbor Biotechnologies company profile →
SoftGenetics
HQ: United States
Website
- Description: Provider of genetic analysis software for researchers and clinicians, including Mutation Surveyor for Sanger DNA variant detection with custom reporting and user management; NextGENe for NGS SNP/indel, structural variant and transcriptome analysis; Geneticist Assistant for NGS variant interpretation, tracking and coverage confirmation; GeneMarker/HTS/MTP for genotyping, forensic NGS and multiple template processing, compatible with major sequencing systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SoftGenetics company profile →
Diagnoplex
HQ: Switzerland
Website
- Description: Provider of non-invasive colorectal cancer screening tests and diagnostics, including the COLOX colorectal cancer screening test; the company has conducted a 140-patient prospective pilot study demonstrating technical and clinical feasibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagnoplex company profile →
Adverum Biotechnologies
HQ: United States
Website
- Description: Provider of gene therapy, developing medicines with therapeutic benefits. Offerings include Ixo-vec, a gene therapy product candidate for wet age-related macular degeneration designed for single administration, and the OPTIC clinical program investigating the safety, efficacy, and long-term outcomes of Ixo-vec in wet AMD patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adverum Biotechnologies company profile →
Genomic Health
HQ: United States
Website
- Description: Provider of genomic-based diagnostic tests addressing overtreatment and optimal treatment of early-stage cancer. Offers Oncotype DX Breast Recurrence Score for ER+/HER2- breast cancer, Riskguard Hereditary Cancer Test, OncoExTra genomic profiling for advanced/metastatic cancer, and developing colorectal screening (Next Generation Cologuard, blood test) and a Breast Radiation Score.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genomic Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genewiz
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genewiz
2.2 - Growth funds investing in similar companies to Genewiz
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genewiz
4.2 - Public trading comparable groups for Genewiz
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →